<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Genus Plc — News on 6ix</title>
<link>https://6ix.com/company/genus-plc</link>
<description>Latest news and press releases for Genus Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 02 Feb 2026 12:39:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/genus-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835e3e278dffbe2df127771.webp</url>
<title>Genus Plc</title>
<link>https://6ix.com/company/genus-plc</link>
</image>
<item>
<title>Block Listing Return</title>
<link>https://6ix.com/company/genus-plc/news/block-listing-return-2</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/block-listing-return-2</guid>
<pubDate>Mon, 02 Feb 2026 12:39:00 GMT</pubDate>
<description>Genus plc has provided a six-monthly return for its employee share schemes covering the period from August 1, 2025, to January 31, 2026. The Genus plc 2004 Executive Share Option Plan has a remaining balance of 13,897 unallotted securities. The Genus plc Share Incentive Plan 2021 saw 840 securities issued, resulting in a balance of 69,927 unallotted securities. The Genus plc International Share Incentive Plan has a balance of 79,671 unallotted securities, with no securities issued during this pe</description>
</item>
<item>
<title>Total Voting Rights</title>
<link>https://6ix.com/company/genus-plc/news/total-voting-rights-216</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/total-voting-rights-216</guid>
<pubDate>Mon, 02 Feb 2026 11:21:00 GMT</pubDate>
<description>Genus plc announced that as of January 31, 2026, its issued share capital comprises 66,538,294 ordinary shares of 10p each, all of which carry voting rights and none are held in treasury. This total figure of 66,538,294 ordinary shares will serve as the denominator for shareholders calculating their notification obligations under the FCA's Disclosure Guidance and Transparency Rules.
Disclaimer*</description>
</item>
<item>
<title>Successful formation of Chinese porcine JV</title>
<link>https://6ix.com/company/genus-plc/news/successful-formation-of-chinese-porcine-jv</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/successful-formation-of-chinese-porcine-jv</guid>
<pubDate>Mon, 02 Feb 2026 07:00:00 GMT</pubDate>
<description>Genus plc has successfully formed its Chinese porcine joint venture on January 31, 2026, with Beijing Capital Agribusiness, a move expected to accelerate the growth of PIC China. Genus will receive a gross cash payment of US$160 million, estimated at US$140 million net of taxes and costs, in addition to a US$7.5 million milestone payment already recognized. Due to Genus's 49% ownership, PIC China will be deconsolidated from the group's accounts, with further implications to be discussed during t</description>
</item>
<item>
<title>PRP Regulatory Progress – Canada</title>
<link>https://6ix.com/company/genus-plc/news/prp-regulatory-progress-canada</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/prp-regulatory-progress-canada</guid>
<pubDate>Fri, 23 Jan 2026 17:23:00 GMT</pubDate>
<description>Genus PLC has announced a significant regulatory milestone as Canada has approved the use of its PRRS Resistant Pig (PRP) gene edit, a crucial step towards commercialisation in North America. This development follows extensive collaboration with Canadian regulatory bodies and addresses the substantial economic impact of PRRS, which a 2024 study estimated costs the U.S. $1.2 billion annually and increases antibiotic usage by over 200%. Genus is actively pursuing further approvals in key export ma</description>
</item>
<item>
<title>Canada approves pigs resistant to porcine reproductive and respiratory syndrome viruses for use in food and feed</title>
<link>https://6ix.com/company/genus-plc/news/canada-approves-pigs-resistant-to-porcine-reproductive-and-respiratory-syndrome-viruses-for-use-in-food-and-feed</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/canada-approves-pigs-resistant-to-porcine-reproductive-and-respiratory-syndrome-viruses-for-use-in-food-and-feed</guid>
<pubDate>Fri, 23 Jan 2026 16:42:00 GMT</pubDate>
<description>Porcine reproductive and respiratory syndrome viruses (PRRSV) are one of the most devastating classes of viruses affecting farmed pigs, representing significant losses for Canada's producers and higher prices at the store for Canadian consumers.</description>
</item>
<item>
<title>Half Year Trading Update – Ahead of expectations</title>
<link>https://6ix.com/company/genus-plc/news/half-year-trading-update-ahead-of-expectations</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/half-year-trading-update-ahead-of-expectations</guid>
<pubDate>Fri, 16 Jan 2026 07:00:00 GMT</pubDate>
<description>Genus PLC has announced a strong first half for fiscal year 2026, with expected adjusted profit before tax of approximately £50 million, exceeding expectations. Including a BCA milestone payment, this figure rises to approximately £55.6 million. The company anticipates full-year adjusted profit before tax, excluding the BCA payment, to be moderately above the top-end of current market expectations, which range from £82.7 million to £85.0 million. Regulatory approval for the Chinese porcine joint</description>
</item>
<item>
<title>Director/PDMR Shareholding</title>
<link>https://6ix.com/company/genus-plc/news/directorpdmr-shareholding-159</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/directorpdmr-shareholding-159</guid>
<pubDate>Thu, 27 Nov 2025 07:00:00 GMT</pubDate>
<description>Genus plc announced on November 27, 2025, that Restricted Share Units were granted on November 26, 2025, under the Genus 2025 Long Term Incentive Plan to Executive Directors and members of the Genus Executive Leadership Team. These awards, which vest in September 2028, were granted at a price of 0p per share, with volumes ranging from 4,436 to 18,327 units for individuals including the Chief Executive Officer, Chief Financial Officer, and other senior executives.
Disclaimer*</description>
</item>
<item>
<title>Results of AGM</title>
<link>https://6ix.com/company/genus-plc/news/results-of-agm-9</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/results-of-agm-9</guid>
<pubDate>Wed, 19 Nov 2025 12:12:00 GMT</pubDate>
<description>Genus PLC announced that all resolutions presented at its Annual General Meeting on November 19, 2025, were passed by poll, with resolutions 1 to 16 approved as ordinary resolutions and resolutions 17 to 20 as special resolutions. Notably, the final dividend of 21.7 pence per ordinary share received 100% in favour, and the re-appointment of PricewaterhouseCoopers LLP as auditor also achieved 99.99% approval. The total number of ordinary shares eligible to vote was 66,537,765, with 70.37% of the </description>
</item>
<item>
<title>Non-Executive Director Appointments</title>
<link>https://6ix.com/company/genus-plc/news/non-executive-director-appointments</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/non-executive-director-appointments</guid>
<pubDate>Wed, 19 Nov 2025 07:00:00 GMT</pubDate>
<description>Genus PLC announced the appointment of two Non-Executive Directors, Dr Celia Baxter, effective November 19, 2025, and Dr Robert Reiter, effective January 1, 2026. Dr Baxter brings extensive global experience in Human Resources, Strategy, Branding, Mergers and Acquisitions, and Change Management, with a background in FTSE 100 and FTSE 250 companies. Dr Reiter, a plant geneticist, has significant experience in crop agriculture, R&D, and supply chain leadership, notably overseeing an annual investm</description>
</item>
<item>
<title>AGM Trading Update</title>
<link>https://6ix.com/company/genus-plc/news/agm-trading-update-20</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/agm-trading-update-20</guid>
<pubDate>Wed, 19 Nov 2025 07:00:00 GMT</pubDate>
<description>Genus PLC has reported a strong start to the financial year ending 31 October 2025, with the Board anticipating Group FY26 adjusted profit before tax to be modestly ahead of the midpoint of current market expectations, which average £80.5 million. PIC demonstrated robust growth across all regions, particularly in China, while ABS operating profit was slightly lower than anticipated due to phasing, with an expected improvement in the second half of the year.
Disclaimer*</description>
</item>
<item>
<title>Notification of Major Holdings</title>
<link>https://6ix.com/company/genus-plc/news/notification-of-major-holdings-14</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/notification-of-major-holdings-14</guid>
<pubDate>Tue, 14 Oct 2025 15:02:00 GMT</pubDate>
<description>Baillie Gifford & Co. has notified Genus PLC on October 14, 2025, that it crossed a threshold on October 13, 2025, regarding voting rights. Baillie Gifford & Co. now holds a total of 3,318,821 voting rights attached to shares, representing 4.99% of the total voting rights in Genus PLC. This 4.99% is comprised entirely of indirect voting rights. The firm's registered office is in Edinburgh, United Kingdom.
Disclaimer*</description>
</item>
<item>
<title>Notice of AGM</title>
<link>https://6ix.com/company/genus-plc/news/notice-of-agm-41</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/notice-of-agm-41</guid>
<pubDate>Fri, 10 Oct 2025 06:00:00 GMT</pubDate>
<description>Genus PLC has released its Annual Report for 2025, alongside the Notice of Annual General Meeting and Form of Proxy, to its shareholders. These documents are accessible on the company's website at www.genusplc.com and have also been submitted to the National Storage Mechanism for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The Annual General Meeting is scheduled for Wednesday, November 19, 2025, at 11:00 am at Buchanan Communications in London, with a summary of propose</description>
</item>
<item>
<title>HSBC HOLDINGS PLC ANNOUNCES RESULTS OF ITS TENDER OFFERS FOR FOUR SERIES OF NOTES</title>
<link>https://6ix.com/company/genus-plc/news/hsbc-holdings-plc-announces-results-of-its-tender-offers-for-four-series-of-notes-78</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/hsbc-holdings-plc-announces-results-of-its-tender-offers-for-four-series-of-notes-78</guid>
<pubDate>Tue, 09 Sep 2025 10:52:00 GMT</pubDate>
<description>HSBC Holdings plc (the 'Company', 'we' or 'us') today announces the results of its previously announced four separate offers to purchase for cash any and all of the outstanding series of notes listed in the table below. We refer to the outstanding notes listed in the table below collectively as the 'Notes' and separately as a 'series' of Notes. We refer to each offer to purchase a series of Notes as an 'Offer', and collectively as the 'Offers'.</description>
</item>
<item>
<title>Additional Listing</title>
<link>https://6ix.com/company/genus-plc/news/additional-listing-12</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/additional-listing-12</guid>
<pubDate>Mon, 08 Sep 2025 15:05:00 GMT</pubDate>
<description>Genus PLC announced an application for the admission of 500,000 new ordinary shares, each with a nominal value of 10p, to the Financial Conduct Authority and the London Stock Exchange. These shares will be allotted to the Company's Employee Benefit Trust to satisfy share awards under shareholder-approved share plans. Admission to the Official List and trading on the London Stock Exchange is expected to occur on September 12, 2025. These new shares will rank equally with the company's existing or</description>
</item>
<item>
<title>Accelerated Chinese porcine JV formation</title>
<link>https://6ix.com/company/genus-plc/news/accelerated-chinese-porcine-jv-formation</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/accelerated-chinese-porcine-jv-formation</guid>
<pubDate>Thu, 04 Sep 2025 06:00:00 GMT</pubDate>
<description>Genus PLC announced an acceleration of its Chinese porcine joint venture formation with Beijing Capital Agribusiness Co. Ltd (BCA). Genus will receive a gross cash payment of US$160 million, with an estimated US$140 million net of withholding tax and transaction costs. An accelerated milestone payment of US$7.5 million will be received upon approval for the joint venture formation. Genus will also receive intellectual property royalties from the joint venture on PRP sales in China and dividends </description>
</item>
<item>
<title>Preliminary results</title>
<link>https://6ix.com/company/genus-plc/news/preliminary-results-15</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/preliminary-results-15</guid>
<pubDate>Thu, 04 Sep 2025 06:00:00 GMT</pubDate>
<description>Preliminary results.</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/genus-plc/news/holdings-in-company-154</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/holdings-in-company-154</guid>
<pubDate>Wed, 06 Aug 2025 09:51:00 GMT</pubDate>
<description>Holding(s) in Company.</description>
</item>
<item>
<title>Block Listing Six Monthly Return</title>
<link>https://6ix.com/company/genus-plc/news/block-listing-six-monthly-return-25</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/block-listing-six-monthly-return-25</guid>
<pubDate>Fri, 01 Aug 2025 09:10:00 GMT</pubDate>
<description>Block Listing Six Monthly Return.</description>
</item>
<item>
<title>FY25 Trading Update</title>
<link>https://6ix.com/company/genus-plc/news/fy25-trading-update-2</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/fy25-trading-update-2</guid>
<pubDate>Tue, 15 Jul 2025 06:00:00 GMT</pubDate>
<description>FY25 Trading Update.</description>
</item>
<item>
<title>Appointment of Financial Adviser & joint Broker</title>
<link>https://6ix.com/company/genus-plc/news/appointment-of-financial-adviser-and-joint-broker</link>
<guid isPermaLink="true">https://6ix.com/company/genus-plc/news/appointment-of-financial-adviser-and-joint-broker</guid>
<pubDate>Fri, 09 May 2025 08:25:00 GMT</pubDate>
<description>Appointment of Financial Adviser & joint Broker.</description>
</item>
</channel>
</rss>